Insider: Garg Pushkal EVP Chief R&D - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 18,693 | 0 | 18,693 |
| Value | $5,960,263.05 | $0.00 | $5,960,263.05 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/05/2026 | DDS | 500 | Direct | COM | $326.08 | $163,040.00 | 18,693 |
| 03/05/2026 | DDS | 740 | Direct | COM | $323.55 | $239,427.00 | 19,703 |
| 03/05/2026 | DDS | 654 | Direct | COM | $322.33 | $210,803.82 | 20,443 |
| 03/05/2026 | DDS | 510 | Direct | COM | $324.59 | $165,540.90 | 19,193 |
| 03/04/2026 | DDS | 215 | Direct | COM | $320.81 | $68,974.15 | 22,983 |
| 03/04/2026 | DDS | 106 | Direct | COM | $319.03 | $33,817.18 | 23,300 |
| 03/04/2026 | DDS | 289 | Direct | COM | $321.82 | $93,005.98 | 22,694 |
| 03/04/2026 | DDS | 102 | Direct | COM | $320.01 | $32,641.02 | 23,198 |
| 03/04/2026 | DDS | 272 | Direct | COM | $324.88 | $88,367.36 | 21,305 |
| 03/04/2026 | DDS | 350 | Direct | COM | $323.01 | $113,053.50 | 22,344 |
| 03/04/2026 | DDS | 208 | Direct | COM | $325.67 | $67,739.36 | 21,097 |
| 03/04/2026 | DDS | 767 | Direct | COM | $323.84 | $248,385.28 | 21,577 |
| 03/03/2026 | DDS | 355 | Direct | COM | $316.74 | $112,442.70 | 24,826 |
| 03/03/2026 | DDS | 317 | Direct | COM | $319.06 | $101,142.02 | 24,509 |
| 03/03/2026 | DDS | 640 | Direct | COM | $320.48 | $205,107.20 | 23,869 |
| 03/03/2026 | DDS | 463 | Direct | COM | $321.50 | $148,854.50 | 23,406 |
| 03/02/2026 | DDS | 277 | Direct | COM | $325.63 | $90,199.51 | 26,474 |
| 03/02/2026 | DDS | 421 | Direct | COM | $326.81 | $137,587.01 | 26,053 |
| 03/02/2026 | DDS | 50 | Direct | COM | $323.62 | $16,181.00 | 26,848 |
| 03/02/2026 | DDS | 353 | Direct | COM | $327.67 | $115,667.51 | 25,700 |
| 03/02/2026 | DDS | 97 | Direct | COM | $324.65 | $31,491.05 | 26,751 |
| 03/02/2026 | DDS | 107 | Direct | COM | $328.71 | $35,171.97 | 25,593 |
| 03/02/2026 | DDS | 42 | Direct | COM | $332.64 | $13,970.88 | 25,181 |
| 03/02/2026 | DDS | 101 | Direct | COM | $331.93 | $33,524.93 | 25,223 |
| 03/02/2026 | DDS | 87 | Direct | COM | $330.85 | $28,783.95 | 25,324 |
| 1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research